KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Total Debt (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Total Debt for 12 consecutive years, with $49.1 million as the latest value for Q4 2025.

  • Quarterly Total Debt changed N/A to $49.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $49.1 million for FY2025, N/A changed from the prior year.
  • Total Debt hit $49.1 million in Q4 2025 for ClearPoint Neuro, up from $29.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $49.1 million in Q4 2025 to a low of $9.8 million in Q4 2021.
  • Historically, Total Debt has averaged $17.1 million across 4 years, with a median of $9.9 million in 2023.
  • Biggest YoY gain for Total Debt was 1865.74% in 2021; the steepest drop was 60.65% in 2021.
  • Year by year, Total Debt stood at $9.8 million in 2021, then rose by 0.56% to $9.9 million in 2022, then grew by 0.57% to $9.9 million in 2023, then skyrocketed by 393.29% to $49.1 million in 2025.
  • Business Quant data shows Total Debt for CLPT at $49.1 million in Q4 2025, $29.2 million in Q3 2025, and $28.8 million in Q2 2025.